Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-FCGR2A Antibody (5M338) is an antibody targeting FCGR2A. Anti-FCGR2A Antibody (5M338) can be used in ELISA,WB.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 μL | $207 | 7-10 days | 7-10 days | |
| 100 μL | $349 | 7-10 days | 7-10 days |
| Description | Anti-FCGR2A Antibody (5M338) is an antibody targeting FCGR2A. Anti-FCGR2A Antibody (5M338) can be used in ELISA,WB. |
| Synonyms | fcRII-a, FCRIIA, FcgRIIA, FCGR2A1, FCGR2A, FCGR2, FCG2, Fc γ RIIA, Fc gamma RIIA, CD32A |
| Ig Type | Rabbit IgG |
| Clone | 5M338 |
| Reactivity | Human |
| Verified Activity | Western Blot -Positive WB detected in: THP-1 whole cell lysate -All lanes: CD32 antibody at 1:1000 -Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution -Predicted band size: 35, 36 kDa -Observed band size: 45 kDa |
| Application | |
| Recommended Dose | WB:1:500-1:5000. |
| Antibody Type | Monoclonal |
| Subcellular Localization | Cell membrane; Single-pass type I membrane protein. |
| Tissue Specificity | Found on monocytes, neutrophils and eosinophil platelets. |
| Construction | Recombinant Antibody |
| Purification | Affinity-chromatography |
| Appearance | Liquid |
| Formulation | Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Research Background | Binds to the Fc region of immunoglobulins gamma. Low affinity receptor. By binding to IgG it initiates cellular responses against pathogens and soluble antigens. Promotes phagocytosis of opsonized antigens. |
| Conjucates | Unconjugated |
| Immunogen | A synthetic peptide: Human CD32 |
| Antigen Species | Human |
| Gene Name | FCGR2A |
| Gene ID | |
| Uniprot ID | |
| Biology Area | Immunology, Stem cells |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.